Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market. 

We currently have 28 topical Abbreviated New Drug Applications (ANDAs) on file at the FDA, representing a total addressable market of $1.5 billion (IMS, September 2015). We also have one injectable Prior Approval Supplement (PAS) on file with the FDA. 

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Click to view the Teligent, Inc. Corporate Presentation.

Jenniffer Collins, CFO

‘’As we grow, we will keep our focus on execution, ownership and delivering on what we promise.’’

print email
Price Data